Lotti M, Caroldi S, Moretto A, Johnson M K, Fish C J, Gopinath C, Roberts N L
Toxicol Appl Pharmacol. 1987 Mar 30;88(1):87-96. doi: 10.1016/0041-008x(87)90272-9.
Systemic injection of diisopropyl phosphorofluoridate (DFP; 1 mg/kg, sc) causes delayed neuropathy in hens. This effect is associated with a high level of organophosphorylation of neuropathy target esterase (NTE) followed by an intramolecular rearrangement called "aging." Phenylmethanesulfonyl fluoride (PMSF) also attacks the active center of NTE but "aging" cannot occur. This compound does not cause neuropathy and protects against a subsequent challenge systemic dose of DFP. Intraarterial injection of DFP (0.185 mg/kg) into only one leg of hens caused a high NTE inhibition (greater than 80%) in the sciatic nerve of the injected leg, but not in other parts of the nervous system (37% average). A unilateral neuropathy with typical histopathological lesions developed in the injected leg. PMSF (0.55 mg/kg) injected into each sciatic artery caused 47% inhibition of sciatic nerve NTE but only 17-22% inhibition of NTE elsewhere; it did not produce clinical or histopathological lesions. When these hens were challenged with DFP (1 mg/kg, sc), high inhibition of residual-free NTE (greater than 85%) occurred throughout the nervous system and clinical signs of a syndrome different from the classical delayed neuropathy developed: this spinal cord type of ataxia was associated with histopathological lesions in the spinal cord but not in peripheral nerve. PMSF (1 mg/kg) injected into only one sciatic artery caused selective protective inhibition of sciatic nerve NTE of that leg. After systemic challenge by DFP, clinical effects expressed were a combination of spinal cord ataxia plus unilateral peripheral neuropathy. The challenge dose of DFP (1 mg/kg, sc) was insufficient to produce clear histopathological lesions in unprotected peripheral nerves although spinal lesions were found in these hens. Thus clinical evaluation of the peripheral nervous system by means of walking tests and a simple test of "leg retraction" reflexes was more sensitive and specific in diagnosis of peripheral neuropathy than was the histopathology.
向母鸡体内系统性注射氟磷酸二异丙酯(DFP;1毫克/千克,皮下注射)会导致母鸡出现迟发性神经病变。这种效应与神经病变靶酯酶(NTE)的高水平有机磷酸化有关,随后会发生一种称为“老化”的分子内重排。苯甲基磺酰氟(PMSF)也会攻击NTE的活性中心,但不会发生“老化”。这种化合物不会导致神经病变,并且能保护机体免受后续系统性剂量DFP的攻击。仅向母鸡的一条腿进行动脉内注射DFP(0.185毫克/千克),会使注射腿的坐骨神经中的NTE受到高度抑制(大于80%),但在神经系统的其他部位则不会(平均为37%)。注射腿出现了伴有典型组织病理学损伤的单侧神经病变。向每条坐骨动脉注射PMSF(0.55毫克/千克)会使坐骨神经NTE受到47%的抑制,但在其他部位NTE仅受到17 - 22%的抑制;它不会产生临床或组织病理学损伤。当用DFP(1毫克/千克,皮下注射)对这些母鸡进行攻击时,整个神经系统中残留的游离NTE受到高度抑制(大于85%),并且出现了一种与经典迟发性神经病变不同的综合征的临床症状:这种脊髓型共济失调与脊髓中的组织病理学损伤有关,但与周围神经无关。仅向一条坐骨动脉注射PMSF(1毫克/千克)会导致该腿坐骨神经NTE受到选择性保护抑制。在接受DFP系统性攻击后,所表现出的临床效应是脊髓共济失调与单侧周围神经病变的组合。DFP的攻击剂量(1毫克/千克,皮下注射)不足以在未受保护的周围神经中产生明显的组织病理学损伤,尽管在这些母鸡中发现了脊髓病变。因此,通过行走测试和简单的“腿部回缩”反射测试对外周神经系统进行临床评估,在诊断周围神经病变方面比组织病理学更敏感、更具特异性。